External negatives threaten pharmaceutical industry

A host of new external negatives have emerged over the past weeks, further casting a shadow over the long-term prospect of local pharmaceutical industry in terms of research and development projects.

The heavy fine by the Free Trade Commission over undue business practice of 10 pharmaceutical firms, as well as the government's relentless price cut of 1,451 medicines, could dampen the vitalit...